These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28816137)

  • 1. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review.
    Buckley H; Wilson C; Ajithkumar T
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):111-127. PubMed ID: 28816137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose rate endorectal brachytherapy for rectal cancer: A state-of-the-art review.
    Cheng T; Peng R; Qu A; Wang H
    Cancer Sci; 2023 Nov; 114(11):4145-4156. PubMed ID: 37702196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study.
    Rijkmans EC; Cats A; Nout RA; van den Bongard DHJG; Ketelaars M; Buijsen J; Rozema T; Franssen JH; Velema LA; van Triest B; Marijnen CAM
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):908-917. PubMed ID: 28366579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
    Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
    Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects.
    Nout RA; Devic S; Niazi T; Wyse J; Boutros M; Pelsser V; Vuong T
    Brachytherapy; 2016; 15(4):477-484. PubMed ID: 27090225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
    Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
    Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
    Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
    Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
    Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes.
    Lee JH; Kim SH; Kim JG; Cho HM; Shim BY
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):431-8. PubMed ID: 20732756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
    Rijkmans EC; Marijnen CAM; van Triest B; Ketelaars M; Cats A; Inderson A; van den Ende RPJ; Laman MS; Kerkhof EM; Nout RA
    Radiother Oncol; 2019 Apr; 133():176-182. PubMed ID: 30935576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative clinical end points in rectal cancer--are we getting closer?
    Glynne-Jones R; Mawdsley S; Pearce T; Buyse M
    Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose rate brachytherapy in the management of anal cancer: A review.
    Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
    Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
    Ceelen WP; Van Nieuwenhove Y; Fierens K
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006041. PubMed ID: 19160264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
    Ortholan C; Romestaing P; Chapet O; Gerard JP
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
    De Caluwé L; Van Nieuwenhove Y; Ceelen WP
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006041. PubMed ID: 23450565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study.
    Rijkmans EC; van Triest B; Nout RA; Kerkhof EM; Buijsen J; Rozema T; Franssen JH; Velema LA; Laman MS; Cats A; Marijnen CAM
    Radiother Oncol; 2018 Mar; 126(3):417-423. PubMed ID: 29398154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer.
    Dizdarevic E; Frøstrup Hansen T; Pløen J; Henrik Jensen L; Lindebjerg J; Rafaelsen S; Jakobsen A; Appelt A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):556-563. PubMed ID: 31707122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study.
    Lin JZ; Peng JH; Qdaisat A; Lu ZH; Wu XJ; Chen G; Ding PR; Li LR; Gao YH; Zeng ZF; Wan DS; Pan ZZ
    Oncotarget; 2016 Aug; 7(35):57317-57326. PubMed ID: 27374175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.